, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

up 47.79 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Buy with price target $659 by Brean Capital

Posted on: Tuesday,  Aug 4, 2015  4:25 PM ET by Brean Capital

Brean Capital rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 08/04/2015. Previously Brean Capital rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on
09/02/2014., when the stock price was $364.02. Since then, Regeneron Pharmaceuticals, Inc. has gained 47.79% as of 01/27/2016's recent price of $538.00.
If you would have followed the previous Brean Capital's recommendation on REGN, you would have gained 47.79% of your investment in 512 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Brean Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2015 4:25 PM Buy
584.30 659.00
as of 8/27/2015
1 Week down  -7.08 %
1 Month up  3.25 %
3 Months up  9.47 %
1 YTD down  -7.92 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2014 9:25 AM Buy
411.51 450.00
9/2/2014 2:25 PM Buy
364.02 390.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy